Massachusetts Financial Services Co. MA Decreases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Massachusetts Financial Services Co. MA trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,075,163 shares of the medical equipment provider's stock after selling 62,312 shares during the period. Massachusetts Financial Services Co. MA owned about 0.30% of Intuitive Surgical worth $561,192,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Bennett Selby Investments LP raised its position in shares of Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after acquiring an additional 17 shares during the last quarter. Onefund LLC increased its position in shares of Intuitive Surgical by 1.9% during the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after buying an additional 18 shares during the period. LVW Advisors LLC raised its stake in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. lifted its holdings in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC boosted its position in Intuitive Surgical by 3.7% during the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after acquiring an additional 19 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Remove Ads

Insider Activity

In related news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the firm's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company's stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 over the last three months. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ISRG. CICC Research initiated coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price objective for the company. Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Truist Financial reduced their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a research report on Monday, March 17th. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, UBS Group lifted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $611.86.

Intuitive Surgical Stock Down 8.7 %

ISRG stock traded down $43.03 during trading on Friday, reaching $451.58. The stock had a trading volume of 4,106,917 shares, compared to its average volume of 1,542,647. The company has a market capitalization of $160.84 billion, a price-to-earnings ratio of 70.45, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company's 50 day moving average is $545.18 and its two-hundred day moving average is $532.30.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.